Cargando…

Genomic NGFB variation and multiple sclerosis in a case control study

BACKGROUND: Nerve growth factor β (NGFB) is involved in cell proliferation and survival, and it is a mediator of the immune response. ProNGF, the precursor protein of NGFB, has been shown to induce cell death via interaction with the p75 neurotrophin receptor. In addition, this neurotrophin is diffe...

Descripción completa

Detalles Bibliográficos
Autores principales: Akkad, Denis A, Kruse, Niels, Arning, Larissa, Gold, Ralf, Epplen, Jörg T
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613874/
https://www.ncbi.nlm.nih.gov/pubmed/19063739
http://dx.doi.org/10.1186/1471-2350-9-107
_version_ 1782163201947860992
author Akkad, Denis A
Kruse, Niels
Arning, Larissa
Gold, Ralf
Epplen, Jörg T
author_facet Akkad, Denis A
Kruse, Niels
Arning, Larissa
Gold, Ralf
Epplen, Jörg T
author_sort Akkad, Denis A
collection PubMed
description BACKGROUND: Nerve growth factor β (NGFB) is involved in cell proliferation and survival, and it is a mediator of the immune response. ProNGF, the precursor protein of NGFB, has been shown to induce cell death via interaction with the p75 neurotrophin receptor. In addition, this neurotrophin is differentially expressed in males and females. Hence NGFB is a good candidate to influence the course of multiple sclerosis (MS), much like in the murine model of experimental autoimmune encephalomyelitis (EAE). METHODS: Ten single nucleotide polymorphisms (SNPs) were genotyped in the NGFB gene in up to 1120 unrelated MS patients and 869 controls. Expression analyses were performed for selected MS patients in order to elucidate the possible functional relevance of the SNPs. RESULTS: Significant association of NGFB variations with MS is evident for two SNPs. NGFB mRNA seems to be expressed in sex- and disease progression-related manner in peripheral blood mononuclear cells. CONCLUSION: NGFB variation and expression levels appear as modulating factors in the development of MS.
format Text
id pubmed-2613874
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26138742009-01-06 Genomic NGFB variation and multiple sclerosis in a case control study Akkad, Denis A Kruse, Niels Arning, Larissa Gold, Ralf Epplen, Jörg T BMC Med Genet Research Article BACKGROUND: Nerve growth factor β (NGFB) is involved in cell proliferation and survival, and it is a mediator of the immune response. ProNGF, the precursor protein of NGFB, has been shown to induce cell death via interaction with the p75 neurotrophin receptor. In addition, this neurotrophin is differentially expressed in males and females. Hence NGFB is a good candidate to influence the course of multiple sclerosis (MS), much like in the murine model of experimental autoimmune encephalomyelitis (EAE). METHODS: Ten single nucleotide polymorphisms (SNPs) were genotyped in the NGFB gene in up to 1120 unrelated MS patients and 869 controls. Expression analyses were performed for selected MS patients in order to elucidate the possible functional relevance of the SNPs. RESULTS: Significant association of NGFB variations with MS is evident for two SNPs. NGFB mRNA seems to be expressed in sex- and disease progression-related manner in peripheral blood mononuclear cells. CONCLUSION: NGFB variation and expression levels appear as modulating factors in the development of MS. BioMed Central 2008-12-08 /pmc/articles/PMC2613874/ /pubmed/19063739 http://dx.doi.org/10.1186/1471-2350-9-107 Text en Copyright © 2008 Akkad et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Akkad, Denis A
Kruse, Niels
Arning, Larissa
Gold, Ralf
Epplen, Jörg T
Genomic NGFB variation and multiple sclerosis in a case control study
title Genomic NGFB variation and multiple sclerosis in a case control study
title_full Genomic NGFB variation and multiple sclerosis in a case control study
title_fullStr Genomic NGFB variation and multiple sclerosis in a case control study
title_full_unstemmed Genomic NGFB variation and multiple sclerosis in a case control study
title_short Genomic NGFB variation and multiple sclerosis in a case control study
title_sort genomic ngfb variation and multiple sclerosis in a case control study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613874/
https://www.ncbi.nlm.nih.gov/pubmed/19063739
http://dx.doi.org/10.1186/1471-2350-9-107
work_keys_str_mv AT akkaddenisa genomicngfbvariationandmultiplesclerosisinacasecontrolstudy
AT kruseniels genomicngfbvariationandmultiplesclerosisinacasecontrolstudy
AT arninglarissa genomicngfbvariationandmultiplesclerosisinacasecontrolstudy
AT goldralf genomicngfbvariationandmultiplesclerosisinacasecontrolstudy
AT epplenjorgt genomicngfbvariationandmultiplesclerosisinacasecontrolstudy